Dr. Xavier Luria is the Founder, Chief Executive and Senior Consultant at DDR since 2012. He is former Head of Safety and Efficacy of Medicines at the European Medicines Agency (EMA) where he coordinated regulatory teams from the 27 European Member States in order to evaluate medical products for the whole European Union. He was in charge of several cross-agency projects, including implementation of electronic submissions using eCTD and development of other IT tools, review and reorganization of CHMP's Working Parties, coordination and expansion of the EMA's Scientific Advisory Groups (SAG) and new methodologies on Benefit/Risk assessment. Prior to joining the EMA, Xavier worked for 18 years in the pharmaceutical industry, including 10 years as International Medical Director with responsibilities in clinical development, medical affairs, drug safety and biometry, and some other corporate functions. He has been a member of working groups in the European pharmaceutical industry association (EFPIA). He participated in a number of ICH initiatives and was also a member of the DIA Steering Committee Europe until 2004. He has been involved in a large number of activities with the FDA, Japanese health authorities and European National regulatory bodies.
DDR Network integrates the most highly qualified, experience-based experts to providing appropriate advice and operations to the Life Science industry. In particular, the DDR Network covers a wide range of relevant areas to help companies and academic institutions to ensure efficient development and registration processes.
The DDR Network is composed by experts from all over Europe, USA, Latin America, Israel and Japan and is currently being expanded in India.
Whether a particular area of expertise is not covered by DDR, we ensure to the clients that references to appropriate experts outside the DDR Network will be provided.